227 filings
Page 3 of 12
8-K
a603 hwzr
3 May 22
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
4:08pm
8-K
y8jh6a t0c6
15 Mar 22
Brickell Biotech Reports Fourth Quarter and Full Year 2021
7:33am
8-K
j8ygeykfk2nh
2 Feb 22
Entry into a Material Definitive Agreement
7:37am
8-K
0iq8s ox77ib4
14 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:13pm
8-K
15dn k0vi
9 Nov 21
Brickell Biotech Reports Third Quarter 2021
4:07pm
8-K
tdhbflhcg2 6b4fu8
1 Nov 21
Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
4:29pm
8-K
8gqjcq1z
7 Oct 21
Regulation FD Disclosure
8:30am
8-K
4k5jyb1yh9gqsy2csnxa
7 Oct 21
Regulation FD Disclosure
6:56am
8-K
c52ymv5jy6c 3s5
1 Sep 21
Entry into a Material Definitive Agreement
7:06am
8-K
frliw30z5
12 Aug 21
Brickell Biotech Reports Second Quarter 2021
4:03pm
8-K
ymdto
22 Jul 21
Brickell Biotech Announces $5.0 Million Bought Deal Offering of Common Stock
4:08pm
8-K
60mrspv1no ktwei
17 Jun 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:18pm
8-K
hwt hax23
13 May 21
Brickell Biotech Reports First Quarter 2021
4:04pm
8-K
pgeu0s056td
23 Apr 21
Regulation FD Disclosure
10:02am
8-K
rdbnji nwo68dhaih8
19 Apr 21
Departure of Directors or Certain Officers
4:14pm
8-K
hdq3ness7vp
9 Mar 21
Entry into a Material Definitive Agreement
4:35pm
8-K
d97up1yf
9 Mar 21
Brickell Biotech Reports Fourth Quarter and Full Year 2020
4:06pm
8-K
ejhgl1xza7kci04ky
26 Feb 21
Departure of Directors or Certain Officers
4:14pm
8-K
ux5rj
22 Jan 21
Regulation FD Disclosure
8:01am
8-K
fh4jj7svgu
24 Nov 20
Departure of Directors or Certain Officers
8:06am